Estrogen and Progesterone Receptor Expression in Postmenopausal Tamoxifen-Exposed Endometrial Pathologies

By Cohen I.   Beyth Y.   Altaras M.M.   Shapira J.   Tepper R.   Cardoba M.   Yigael D.   Figer A.   Fishman A.   Berenhein J.  

Gynecologic Oncology, Vol. 67, Iss. 1, 1997-10 ,pp. : 8-15

Elsevier

Access to resources Recommend Favorite

Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen

By Fung M.F.K.   Reid A.   Faught W.   Le T.   Chenier C.   Verma S.   Brydon E.   Fung K.F.K.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 154-159

Elsevier

Access to resources Recommend Favorite

Dose-dependent effect of tamoxifen therapy on endometrial pathologies in postmenopausal breast cancer patients

By Cohen I.  

Breast Cancer Research and Treatment, Vol. 53, Iss. 3, 1999-02 ,pp. : 255-262

Springer Publishing Company

Access to resources Recommend Favorite

A Retrospective Study of Tamoxifen and Endometrial Cancer in Breast Cancer Patients

By Robinson D.C.   Bloss J.D.   Schiano M.A.  

Gynecologic Oncology, Vol. 59, Iss. 2, 1995-11 ,pp. : 186-190

Academic Press

Access to resources Recommend Favorite

Prospective Study to Compare Endometrial Cytology and Transvaginal Ultrasonography for Identification of Endometrial Malignancies

By Tsuda H.   Kawabata M.   Yamamoto K.   Inoue T.   Umesaki N.  

Gynecologic Oncology, Vol. 65, Iss. 3, 1997-06 ,pp. : 383-386

Elsevier

Access to resources Recommend Favorite